You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2025

List of Excipients in API sumatriptan and naproxen sodium


✉ Email this page to a colleague

« Back to Dashboard


Excipients in ANDA-approved (generic) drugs containing sumatriptan and naproxen sodium

Company Ingredient NDC Excipient
Mylan Pharmaceuticals Inc sumatriptan and naproxen sodium 0378-8755 CROSPOVIDONE
Mylan Pharmaceuticals Inc sumatriptan and naproxen sodium 0378-8755 HYPROMELLOSE 2910
Mylan Pharmaceuticals Inc sumatriptan and naproxen sodium 0378-8755 LACTOSE MONOHYDRATE
Mylan Pharmaceuticals Inc sumatriptan and naproxen sodium 0378-8755 MAGNESIUM STEARATE
Mylan Pharmaceuticals Inc sumatriptan and naproxen sodium 0378-8755 POLYETHYLENE GLYCOL 4000
Mylan Pharmaceuticals Inc sumatriptan and naproxen sodium 0378-8755 POVIDONE K30
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for sumatriptan and naproxen sodium

Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

sumatriptan and naproxen sodium drug variants containing CROSPOVIDONE

Company Ingredient NDC
Mylan Pharmaceuticals Inc sumatriptan and naproxen sodium 0378-8755
NorthStar RxLLC sumatriptan and naproxen sodium 16714-891
Sun Pharmaceutical Industries Inc sumatriptan and naproxen sodium 47335-410
Aurobindo Pharma Limited sumatriptan and naproxen sodium 65862-928
Innovida Phamaceutique Corporation sumatriptan and naproxen sodium 71800-901
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: DEXTROSE MONOHYDRATE

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: LECITHIN, SOYBEAN

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MALTODEXTRIN

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 4000

Excipient focus: POVIDONE K30

Excipient focus: POVIDONE K90

Excipient focus: SILICON DIOXIDE

sumatriptan and naproxen sodium drug variants containing SILICON DIOXIDE

Company Ingredient NDC
Mylan Pharmaceuticals Inc sumatriptan and naproxen sodium 0378-8755
NorthStar RxLLC sumatriptan and naproxen sodium 16714-891
Sun Pharmaceutical Industries Inc sumatriptan and naproxen sodium 47335-410
Aurobindo Pharma Limited sumatriptan and naproxen sodium 65862-928
Innovida Phamaceutique Corporation sumatriptan and naproxen sodium 71800-901
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: SODIUM BICARBONATE

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM CITRATE

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

sumatriptan and naproxen sodium drug variants containing TITANIUM DIOXIDE

Company Ingredient NDC
Mylan Pharmaceuticals Inc sumatriptan and naproxen sodium 0378-8755
NorthStar RxLLC sumatriptan and naproxen sodium 16714-891
Sun Pharmaceutical Industries Inc sumatriptan and naproxen sodium 47335-410
Aurobindo Pharma Limited sumatriptan and naproxen sodium 65862-928
Innovida Phamaceutique Corporation sumatriptan and naproxen sodium 71800-901
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links